Debio 0123

· Debiopharm International SA

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Debio 0123, covering 2025-12-05 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors [Phase 1]

See pricing